The risk of infections associated with JAK inhibitors in rheumatoid arthritis: a protocol for a systematic review and meta-analysis

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/43019
• EU PAS number:
  EUPAS35531
• Study ID:
  43019
• Official title and acronym:
  The risk of infections associated with JAK inhibitors in rheumatoid arthritis: a protocol for a systematic review and meta-analysis
• DARWIN EU® study:
  No
• Study countries:
  Portugal
• Study status:
  Planned

Research institutions and networks

Institutions

Association for Innovation and Biomedical Research on Light and Image (AIBILI)

Study timelines

Date when funding contract was signed

Planned: 01/04/2020

Study start date

Planned: 01/04/2020

Date of final study report

Planned: 31/12/2020

Sources of funding

Other

More details on funding

AIBILI

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable